Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Adults | 1 |
| Autism | 1 |
| Body Weight | 1 |
| Drug Therapy | 1 |
| Mental Health | 1 |
| Pervasive Developmental… | 1 |
| Physiology | 1 |
| Symptoms (Individual… | 1 |
Source
| Journal of Autism and… | 1 |
Author
| Andridge, Rebecca | 1 |
| Hellings, Jessica A. | 1 |
| Jain, Seema | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkJain, Seema; Andridge, Rebecca; Hellings, Jessica A. – Journal of Autism and Developmental Disorders, 2016
Loxapine substitution is a promising option for patients with autism spectrum disorder (ASD) who develop antipsychotic-induced metabolic illness. We performed a chart review of 15 adolescents and adults meeting DSM-IV-TR criteria for ASD, all with antipsychotic-associated weight gain, who received low dose loxapine in an attempt to taper or…
Descriptors: Autism, Pervasive Developmental Disorders, Drug Therapy, Adolescents
